• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    B. Braun, Baxter Recall Products Over Quality Concerns

    FIERCE PHARMA

    B. Braun Issues Voluntary Nationwide Recall of 0.9% Sodium Chloride for Injection

    FDA

    B Braun Interventional Systems introduces ACCEL All-Purpose

    PHARMABIZ

    B. Braun Launches Levetiracetam in Sodium Chloride Injection Portfolio

    PR NEWSWIRE

    Enforcement Report - Week of April 10, 2024

    FDA

    B. Braun Launches Heparin Sodium 2,000 Units in 0.9% Sodium Chloride Injection

    PR NEWSWIRE

    B. Braun`s Generic Calcium Gluconate Receives Approval in the U.S.

    FDA

    Enforcement Report - Week of May 24, 2023

    FDA

    Health Canda Issues Recall of B. Braun Medical`s Heparin sodium in 5% Dextrose injection

    HEALTH CANADA

    Enforcement Report - Week of March 15, 2023

    FDA

    Enforcement Report - Week of March 1, 2023

    FDA

    Enforcement Report - Week of December 14, 2022

    FDA

    Healiva® Acquires Critical Cell Therapy Manufacturing Assets From B. Braun

    BUSINESSWIRE

    Enforcement Report - Week of March 23, 2022

    FDA

    B. Braun Medical Inc. Issues Voluntary Nationwide Recall of 0.9% Sodium Chloride for Injection USP 250ML

    FDA

    B Braun`s Generic Lidocaine HCl and Epinephrine Receives Approval in the US

    FDA

    B. Braun Avitum AG and CytoSorbents Corporation Announce Global Agreement

    PRNEWSWIRE

    B. Braun Receives the First and Only FDA Approval for Acetaminophen Injection

    PRNEWSWIRE

    Enforcement Report - Week of May 6, 2020

    FDA

    B. Braun Medical Issues Voluntary Nationwide Recall of One (1) Lot of Ceftazidime for Injection USP and Dextrose Injection USP

    FDA

    B. Braun Medical names new chairman, CEO for 2020

    FIERCE BIOTECH

    Some Drug Prices Jumped on July 1, Including Medicines on Shortage Lists

    BIOSPACE

    B Braun Medical`s Generic Bupivacaine Hydrochloride Receives Approval in US

    FDA

    B Braun Medical`s Generic Lidocaine Hydrochloride Receives Approval in US

    FDA

    Enforcement Report - Week of March 7, 2018

    FDA

    Omni® : Baxter Healthcare Corporation v. B. Braun Medical

    PATENT LITIGATION

    Enforcement Report - Week of December 27, 2017

    FDA

    Patients sue B. Braun alleging defect in replacement knees

    MCALL

    B. Braun Medical Inc. on Health Canada Inspection List

    HEALTH CANADA

    Ofirmev (Acetaminophen): Mallinckrodt Ip V.B. Braun Medical Inc.

    PATENT LITIGATION

    Ofirmev (Acetaminophen): Mallinckrodt & SCR Pharmatop v. B. Braun Medical

    PATENT LITIGATION

    B. Braun Medical Issues Voluntary Nationwide Recall of Lot J5J706, 5% Dextrose Inj USP

    FDA

    Broken Market for Old Drugs Means Price Spikes Are Here to Stay

    BLOOMBERG

    Baxter recalls more than half a million units of saline

    FIERCE PHARMA MANUFACTURING

    FDA Drug Shortages: Potassium Chloride Injection

    FDA

    FDA Drug Shortages: Cefazolin Injection

    FDA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.